article · Egyptian Journal of Chemistry
Background: Pediatric immune thrombocytopenia (ITP) is an autoimmune condition whose cause is unclear and appears to include a number of different factors. Methods: In this investigation, quantitative real-time PCR was used to examine the expression profiles of the miRNA Let-7a-5p in blood samples from children with ITP and healthy controls (HCs). It was also examined whether miRNA Let-7a-5p was associated with ITP clinical characteristic parameters and whether it's potential usage as non-invasive circulating biomarkers for ITP diagnosis. The area under the curve was analysed after the receiver operating characteristic curve was generated.Results: When compared to HCs, ITP patients' levels of the miRNA Let-7a-5p were considerably significant higher (P < 0.0001). Furthermore, there was a strong positive correlation between the expression level of the Let-7a-5p biomarker and the patients' levels of the antiplatelet antibody glycoproteins GPIIIa, GPIIb, and GP1b/IX (r = 0.637, 0.669 and 0.486).For miRNA Let-7a-5p, the biomarker demonstrated excellent specificity (96.8) and sensitivity (100%) at cutoff values of > 18.5. Serum miRNA Let-7a-5p may be used as a possible biomarker to distinguish between HCs and children with ITP.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.21608/ejchem.2024.249718.8897
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.